Related Experiment Video

Updated: Mar 30, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

505

MicroRNAS in endometrial cancer: recent advances and potential clinical applications

Megumi Yanokura1, Kouji Banno1, Miho Iida1

  • 1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.

EXCLI Journal
|November 5, 2015
PubMed

Insights

MicroRNAs (miRNAs) show altered expression in endometrial cancer, offering potential for minimally invasive diagnosis and targeted therapies. Further research is needed to translate these findings into clinical applications for this common gynecological tumor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Endometrial cancer lacks specific early diagnostic biomarkers and effective treatments beyond surgery.
  • MicroRNAs (miRNAs) regulate gene expression and present a potential avenue for novel diagnostic and therapeutic strategies.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in endometrial cancer pathogenesis.
  • To identify potential miRNA biomarkers for early diagnosis and prognosis.
  • To explore miRNA-based therapeutic strategies for endometrial cancer.

Main Methods:

  • Analysis of miRNA expression profiles in endometrial cancer tissues compared to normal tissues.
  • Identification of differentially expressed miRNAs involved in cancer progression.
  • Investigation of miRNA functions in cellular processes like carcinogenesis, invasion, and metastasis.

Main Results:

  • Specific miRNAs, including miR-185, miR-210, and miR-423, were found to be upregulated in endometrial cancer.
  • Downregulation of miRNAs such as miR-let7e, miR-30c, and miR-221 was observed.
  • Other miRNAs like miR-181b, miR-324-3p, and miR-518b showed potential as prognostic biomarkers, and miR-152 demonstrated inhibitory effects on cancer growth.

Conclusions:

  • MicroRNA expression profiling reveals significant alterations in endometrial cancer.
  • Certain miRNAs hold promise as diagnostic and prognostic biomarkers.
  • Targeting miRNAs represents a potential therapeutic approach, though further clinical validation is required.
Keywords:
OncomiRbiomarkerendometrial cancermicroRNAtumor suppressor miR

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K